Genpact Limited filed a Form 8-K/A on September 18, 2026, amending its September 8, 2026 current report to disclose the material terms of the separation agreement and general release entered into with departing Chief Financial Officer Michael Weiner.

Key Highlights

  • CFO departure effective: Michael Weiner stepped down as Chief Financial Officer on September 8, 2026, and will remain employed in a transitional capacity through March 31, 2027.
  • Severance payment: Weiner is eligible to receive $683,500, equal to twelve months of base salary, paid in equal installments over the 12-month period following the Separation Date.
  • Healthcare lump sum: A lump sum cash payment of $45,327 will cover the equivalent cost of continued health care coverage for Weiner, his spouse, and eligible dependents for 18 months following the Separation Date.
  • Prorated bonus payment: A lump sum of $168,534 equals Weiner's target annual bonus for calendar year 2027, prorated for days employed prior to March 31, 2027.
  • Equity treatment: Certain unvested restricted share unit and performance share awards will vest as if Weiner had remained employed for 12 months beyond the Separation Date, with performance share vesting subject to actual attainment of performance objectives.
  • Separation Agreement dated: September 15, 2026, conditioned on Weiner executing a general release of claims and continued compliance with non-compete, non-solicitation, and non-disparagement covenants for one year after the Separation Date.

Genpact Discloses Michael Weiner Separation Terms Following CFO Exit

According to the filing, Genpact Limited (NYSE:G) submitted this amendment because the material terms of the separation arrangement had not yet been finalized at the time of the original Form 8-K filed on September 8, 2026. The Separation Agreement, dated September 15, 2026, was entered into between the company and Weiner to confirm the terms of his departure.

The filing states that through March 31, 2027, Weiner will continue to receive his base salary and accrue the same employee benefits he was eligible to receive prior to stepping down as CFO. On or after March 31, 2027, the filing discloses three categories of payments: a $683,500 severance payment equal to twelve months of base salary, distributed in equal installments over 12 months; a $45,327 lump sum representing the cost of continued health care coverage for 18 months; and a $168,534 lump sum equal to his prorated 2027 target annual bonus.

The filing further discloses that previously vested option awards held by Weiner will remain exercisable for six months following the Separation Date, or until expiration of the term of such option if earlier. All severance payments and benefits are conditioned on Weiner executing a general release of claims against the company and its affiliates, re-executing a substantially similar release at the Separation Date, and complying with covenants prohibiting competitive activities, solicitation of clients and employees, disclosure of confidential information, and disparagement of the company, each subject to applicable law.

What Was Disclosed

This amended filing disclosed the full financial and equity terms of the separation agreement between Genpact Limited and former CFO Michael Weiner, including severance pay, health care coverage costs, a prorated bonus, and the treatment of outstanding equity awards, none of which were finalized at the time of the original filing.